Tear fluid proteomics multimarkers for diabetic retinopathy screening
Open Access
- 7 August 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Ophthalmology
- Vol. 13 (1), 40
- https://doi.org/10.1186/1471-2415-13-40
Abstract
The aim of the project was to develop a novel method for diabetic retinopathy screening based on the examination of tear fluid biomarker changes. In order to evaluate the usability of protein biomarkers for pre-screening purposes several different approaches were used, including machine learning algorithms.Keywords
This publication has 35 references indexed in Scilit:
- Sensitivity and specificity of Norwegian optometrists’ evaluation of diabetic retinopathy in single-field retinal images – a cross-sectional experimental studyBMC Health Services Research, 2013
- A simple diabetes vascular severity staging instrument and its application to a Torres Strait Islander and Aboriginal adult cohort of north AustraliaBMC Health Services Research, 2012
- Impact of diabetes on alpha-crystallins and other heat shock proteins in the eyeJournal of Ocular Biology, Diseases, and Informatics, 2011
- Diabetic retinopathyThe Lancet, 2010
- Tear proteomics in evaporative dry eye diseaseEye, 2010
- Diabetic Retinopathy Screening UpdateClinical Diabetes, 2009
- Proteome profiling of vitreoretinal diseases by cluster analysisProteomics – Clinical Applications, 2008
- The impact of national diabetic retinopathy screening on ophthalmology: the need for urgent planningEye, 2004
- An economic analysis of interventions for diabetes.Diabetes Care, 2000
- Establishment of the human reflex tear two‐dimensional polyacrylamide gel electrophoresis reference map: New proteins of potential diagnostic valueElectrophoresis, 1997